Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05760794 · ClinicalTrials.gov registry record · NA
Barbed-suture Efficiency Study for Sacrocolpopexy
A NA study of Prolapse; Female, sponsored by Wake Forest University Health Sciences.
- Active
- Registry status
- NA
- Development phase
- 52
- Enrollment target
- 1
- Study location
NCT05760794 is a NA study of Prolapse; Female that is active but no longer recruiting, run by Wake Forest University Health Sciences. The registered enrollment target is 52 participants, below the 145-participant average among 3 other Prolapse; Female trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05760794, a NA study of Prolapse; Female, is active but no longer recruiting, sponsored by Wake Forest University Health Sciences.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
Minimally invasive sacrocolpopexy (SCP) performed laparoscopically or with robotic assistance is associated with improved patient-centered outcomes such as faster recovery times, less pain, less bleeding, and shorter hospital stay, however at the expense of longer operating times. One of the time consuming parts of the procedure is vaginal mesh attachment.
Conditions Studied
Interventions
- PROCEDURE Non-barbed delayed absorbable suture
- PROCEDURE Barbed delayed absorbable suture
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2023-06-21 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05760794
The ClinicalTrials.gov registry entry for NCT05760794 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 145-participant average among 3 other Prolapse; Female trials with a reported enrollment target (64% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prolapse; Female appearing as the primary indexed condition, and to 2 interventions - of which Non-barbed delayed absorbable suture is the first listed.
NCT05760794 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT05760794 about?
NCT05760794 is a clinical study titled "Barbed-suture Efficiency Study for Sacrocolpopexy". Minimally invasive sacrocolpopexy (SCP) performed laparoscopically or with robotic assistance is associated with improved patient-centered outcomes such as faster recovery times, less pain, less bleeding, and shorter hospital stay, however at the expense of longer operating times. One of the time co...
What is the current status of trial NCT05760794?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 52 participants. The study started on 2023-06-21. Estimated completion is 2027-12.
What conditions does trial NCT05760794 study?
This clinical trial studies the following conditions: Prolapse; Female.
What interventions are being tested in trial NCT05760794?
The interventions under investigation include: Non-barbed delayed absorbable suture (PROCEDURE), Barbed delayed absorbable suture (PROCEDURE).
Who is sponsoring clinical trial NCT05760794?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05760794 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prolapse; Female
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.